Bioqual (OTCMKTS:BIOQ – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.76) EPS for the quarter, reports. Bioqual had a return on equity of 1.23% and a net margin of 0.81%. The business had revenue of $11.77 million during the quarter.
Bioqual Stock Performance
Shares of Bioqual stock opened at $67.50 on Friday. Bioqual has a 1-year low of $59.00 and a 1-year high of $80.00. The firm’s 50-day moving average price is $68.70 and its two-hundred day moving average price is $71.37. The stock has a market capitalization of $60.75 million, a price-to-earnings ratio of 63.08 and a beta of -0.31.
Bioqual Announces Dividend
The business also recently declared an annual dividend, which will be paid on Monday, October 28th. Shareholders of record on Monday, October 7th will be given a $0.50 dividend. This represents a yield of 0.74%. The ex-dividend date is Monday, October 7th. Bioqual’s dividend payout ratio (DPR) is 46.73%.
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Further Reading
- Five stocks we like better than Bioqual
- 5 Top Rated Dividend Stocks to Consider
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
- Canadian Penny Stocks: Can They Make You Rich?
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
- How Technical Indicators Can Help You Find Oversold Stocks
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
